NIH-funded research R01 grant

Investigating how tuberculosis bacteria use host cholesterol to survive

Official title: How Mtb 3B-hydroxysteroid dehydrogenase accesses host cholesterol

Funded at Washington University · NIH-11211077 · Data updated 2026-11-12

This study is looking at how the tuberculosis bacteria interacts with cholesterol in our bodies and how it might change our immune response to help it survive, so it's aimed at understanding this process better for people with tuberculosis.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionWashington University
NIH-funded
Lab location1 site (Saint Louis, United States)
Project startFebruary 13, 2024
Project endDecember 31, 2028
Funding year2025
Award (this year)$67,754
NIH project number3R01AI178685-02S1
Project IDNIH-11211077 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals diagnosed with tuberculosis or those at high risk of developing the disease.

Less likely to help

Patients who do not have tuberculosis or are not at risk for the disease may not benefit from this research.

What this research studies

This research explores how Mycobacterium tuberculosis (Mtb), the bacteria responsible for tuberculosis, interacts with cholesterol in the human body. It focuses on understanding how Mtb modifies the host's immune response to establish infection and persist despite the body's defenses. The study examines the role of a specific enzyme, 3β-hydroxysteroid dehydrogenase, in altering cholesterol metabolites, which may affect immune signaling. By analyzing samples from infected individuals and animal models, the research aims to uncover the mechanisms by which Mtb accesses and utilizes host cholesterol.

Why it matters

Potential benefit: If successful, this research could lead to new strategies for treating tuberculosis by targeting how the bacteria manipulate cholesterol and the immune response.

How similar studies have gone: Previous research has shown that understanding bacterial interactions with host metabolism can lead to significant advancements in treatment, suggesting this approach has potential for success.

Where this research is happening

  • Washington University
    Saint Louis, United States
    Active

Researchers

  • Principal investigator: Philips, Jennifer a — Washington University
  • Study coordinator: Philips, Jennifer a

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.